HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
